Wanfu Lin
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Extracellular vesicles in disease 3
-
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Changquan Ling (15 shared papers)Binbin Cheng (12 shared papers)Shufang Liang (10 shared papers)Chen Wang (3 shared papers)Shu Li (6 shared papers)Huan Wang (3 shared papers)Juan Du (4 shared papers)Jiaying Yuan (3 shared papers)
In The Last Decade
Wanfu Lin
22 papers receiving 401 citations
Peers
Comparison fields: 5 of 74
- Toxicology 36
- Cancer Research 109
- Complementary and alternative medicine 49
- Pharmacology 45
- Hepatology 39
Countries citing papers authored by Wanfu Lin
This map shows the geographic impact of Wanfu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanfu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanfu Lin more than expected).
Fields of papers citing papers by Wanfu Lin
This network shows the impact of papers produced by Wanfu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanfu Lin. The network helps show where Wanfu Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanfu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2023 | 41 | |
| 3 | 2017 | 35 | |
| 4 | 2018 | 32 | |
| 5 | 2019 | 30 | |
| 6 | 2019 | 28 | |
| 7 | 2018 | 25 | |
| 8 | 2021 | 22 | |
| 9 | 2016 | 20 | |
| 10 | 2018 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2024 | 11 | |
| 13 | 2017 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2024 | 10 | |
| 16 | 2019 | 10 | |
| 17 | 2015 | 9 | |
| 18 | 2018 | 7 | |
| 19 | 2025 | 5 | |
| 20 | 2022 | 3 |
About Wanfu Lin
Wanfu Lin is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Complementary and alternative medicine, having authored 24 papers that have together received 403 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Chromatography in Natural Products (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Extracellular vesicles in disease (3 papers), Phytochemistry and biological activity of medicinal plants (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), MicroRNA in disease regulation (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Toxicology (36 citations), Cancer Research (109 citations), Complementary and alternative medicine (49 citations), Pharmacology (45 citations) and Hepatology (39 citations). Wanfu Lin has collaborated with scholars based in China and Taiwan. Frequent co-authors include Changquan Ling, Binbin Cheng, Shufang Liang, Chen Wang, Shu Li, Huan Wang, Juan Du, Jiaying Yuan, Zifei Yin and Xiaofeng Zhai. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Journal of Integrative Medicine, Oncology Reports, Phytomedicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.